Read as much as you want on, anywhere and anytime, for just 99¢.

Shire PLC, Boston Children’s Hospital announce research collaboration

Continue reading below

Shire PLC, an Irish drug company that runs its Human Genetic Therapies division from Lexington, and Boston Children’s Hospital said Tuesday that they will collaborate on researching treatments for rare pediatric diseases.

Under the terms of the three-year agreement, Shire will make an initial upfront payment to Boston Children’s and will have the opportunity to fund selected research programs, the two companies said in a press release. The amount of the upfront payment was not disclosed in the release.

Boston Children’s is the primary pediatric teaching hospital of Harvard Medical School and the largest provider of health care to Massachusetts children.

Chris Reidy can be reached at
Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of